+
Site Tour

PCRLV 2022: Tricuspid valve intervention – Get it right!

Anita Asgar, Maurizio Taramasso and a panel of experts discuss tricuspid valve intervention, including anatomical factors, choice of treatment, tips and tricks, and the latest clinical data supporting TriClip™ therapy as a first-line treatment option.

Related Videos

PCRLV 2022: TAVI Hemodynamic performance

EuroPCR 2022: Tendyne™

Case Transmission | Tricuspid focus

AV VALVES 2023: Live Case – TEER

Transcatheter Interventions 2022: Breakout

TAVI Summit - TAVR in bicuspid

Navitor™: Voice of the Experts Nicolas Van Mieghem

TAVI 2023: Optimizing TAVI

TAVI Case-Club – Alternative access

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

EuroEcho 2021: MR Treatment (Evidence)

PCR LV 2021: Navitor™ 30-day outcomes

Tendyne™: 6-Year Outcomes

ESC 2021: HF & VHD Guidelines

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Debate: Factor XI inhibitors

TAVI Summit - Cardiac imaging and morphology

Trending Controversies | AV Valves

TAVI 2023: The next level

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline